Clinical Trials Directory

Trials / Sponsors / HAL Allergy

HAL Allergy

Industry · 15 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingA Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mi
House Dust Mite Allergy, House Dust Mite Rhinitis
Phase 32024-09-09
CompletedHAL-MRE1 Subcutaneous Immunotherapy in Ragweed Allergic Patients First-in-human
Rhinitis, Allergic, Rhinoconjunctivitis, Allergic
Phase 12018-11-21
CompletedHAL-MPE1 Safety and Tolerability Study
Peanut Allergy
Phase 12016-12-01
CompletedEfficacy and Safety of SUBLIVAC Phleum for Immunotherapy of Grass Pollen-Allergy
Allergic Rhinitis, Allergic Rhinoconjunctivitis
Phase 22015-09-01
CompletedSUBLIVAC FIX Mite Mixture Dose Tolerability Study
House Dust Mite Allergy
Phase 1 / Phase 22015-05-01
CompletedSUBLIVAC FIX Birch Phase III Short-term Efficacy
Birch Pollen Induced Rhinitis/Rhinoconjunctivitis
Phase 32014-09-01
CompletedHAL-MPE1 First-in-human
Peanut Allergy
Phase 12014-06-01
CompletedPURETHAL Birch RUSH Study
Allergic Rhinitis, Allergic Rhinoconjunctivitis
Phase 42013-09-01
CompletedSUBLIVAC FIX Phleum Pratense DT/DRF
Allergic Rhinitis, Allergic Rhinoconjunctivitis
Phase 22012-09-01
CompletedSUBLIVAC FIX Birch Dose Tolerability/Dose Range Finding
Allergic Rhinitis, Allergic Rhinoconjunctivitis
Phase 22012-07-01
CompletedPURETHAL® Mites Dose Range Finding Study in Patients With Persistent Allergic Rhinitis/Rhinoconjunctivitis
Allergic Rhinitis, Allergic Rhinoconjunctivitis
Phase 22011-09-01
CompletedPURETHAL Grasses Rush Study
Allergic Rhinitis, Allergic Rhinoconjunctivitis
Phase 42010-02-01
CompletedStudy With High Dose PURETHAL Mites in Allergic Rhinitis/Rhinoconjunctivitis Patients
Allergic Rhinitis, Allergic Rhinoconjunctivitis
Phase 22009-08-01
CompletedSUBLIVAC® Birch PROBE Study
Seasonal Rhinitis and/or Rhinoconjunctivitis, Birch Pollen Allergy
Phase 22009-07-01
CompletedTwin SUBLIVAC® Grasses Clinical Efficacy Study
Rhinitis, Allergic, Seasonal, Conjunctivitis, Allergic
Phase 32006-09-01